TYP-1-INTERFERON-DIAGNOSEMITTEL

European patent · EP2473636 · In force

Register entry

Publication number
EP2473636
Application number
EP10814513
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 2, 2010
Published
Jul 11, 2012
Granted
Oct 26, 2016
Protection ends at the latest
Sep 1, 2030
Next annual fee due
Sep 30, 2027
IPC classes
C12Q 1/68 (2006.01)
Priority
US 239630 P 03.09.2009
PCT application
PCT/US2010/047721 02.09.2010
PCT publication
WO2011/028933 10.03.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  4. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  5. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  6. Oct 26, 2016

    Granted

    Published in Swissreg on 26.10.2016

Parties

Holder

MedImmune, LLC

One MedImmune Way, Gaithersburg, MD 20878, US

Inventor

HIGGS, Brandon

Gaithersburg, MD 20878, US

ZHU, Wei

Boyds, MD 20841, US

MOREHOUSE, Chris

Middletown, MD 21769, US

WHITE, Barbara

Finksburg, MD 21048, US

JALLAL, Bahija

Potomac, MD 20854, US

YAO, Yihong

Boyds, MD 20854, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.